QTX3046 in Patients With KRAS G12D Mutations
QTX3046 in Patients With KRAS G12D Mutations
Active, not recruiting · NCT06428500 · Registry updated 2025-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QTX3046 in Patients With KRAS G12D Mutations | Advanced Solid Tumor | Active, not recruiting | Phase 1 | 2025-07-25 | NCT06428500 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quanta Therapeutics | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Cancer Center | Durham | United States | 3 |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | United States | 45 |
| South Texas Accelerated Research Therapeutics, LLC Midwest | Grand Rapids | United States | 2 |
| South Texas Accelerated Research Therapeutics, LLC San Antonio | San Antonio | United States | 2 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |